| Product Code: ETC10601171 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Jordan Human Microbiome-Based Drugs and Diagnostics Market Overview |
3.1 Jordan Country Macro Economic Indicators |
3.2 Jordan Human Microbiome-Based Drugs and Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Jordan Human Microbiome-Based Drugs and Diagnostics Market - Industry Life Cycle |
3.4 Jordan Human Microbiome-Based Drugs and Diagnostics Market - Porter's Five Forces |
3.5 Jordan Human Microbiome-Based Drugs and Diagnostics Market Revenues & Volume Share, By Drug Category, 2021 & 2031F |
3.6 Jordan Human Microbiome-Based Drugs and Diagnostics Market Revenues & Volume Share, By Diagnostic Category, 2021 & 2031F |
3.7 Jordan Human Microbiome-Based Drugs and Diagnostics Market Revenues & Volume Share, By Target Organism, 2021 & 2031F |
3.8 Jordan Human Microbiome-Based Drugs and Diagnostics Market Revenues & Volume Share, By Application Area, 2021 & 2031F |
3.9 Jordan Human Microbiome-Based Drugs and Diagnostics Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 Jordan Human Microbiome-Based Drugs and Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Jordan driving the demand for microbiome-based drugs and diagnostics. |
4.2.2 Growing awareness among healthcare professionals and patients about the importance of microbiome in maintaining health. |
4.2.3 Government initiatives to promote research and development in the field of microbiome-based therapies. |
4.3 Market Restraints |
4.3.1 Limited availability of skilled professionals with expertise in microbiome research and development. |
4.3.2 Stringent regulations and approval processes for microbiome-based drugs and diagnostics in Jordan. |
5 Jordan Human Microbiome-Based Drugs and Diagnostics Market Trends |
6 Jordan Human Microbiome-Based Drugs and Diagnostics Market, By Types |
6.1 Jordan Human Microbiome-Based Drugs and Diagnostics Market, By Drug Category |
6.1.1 Overview and Analysis |
6.1.2 Jordan Human Microbiome-Based Drugs and Diagnostics Market Revenues & Volume, By Drug Category, 2021 - 2031F |
6.1.3 Jordan Human Microbiome-Based Drugs and Diagnostics Market Revenues & Volume, By Probiotics, 2021 - 2031F |
6.1.4 Jordan Human Microbiome-Based Drugs and Diagnostics Market Revenues & Volume, By Prebiotics, 2021 - 2031F |
6.1.5 Jordan Human Microbiome-Based Drugs and Diagnostics Market Revenues & Volume, By Symbiotics, 2021 - 2031F |
6.1.6 Jordan Human Microbiome-Based Drugs and Diagnostics Market Revenues & Volume, By Fecal Transplant, 2021 - 2031F |
6.2 Jordan Human Microbiome-Based Drugs and Diagnostics Market, By Diagnostic Category |
6.2.1 Overview and Analysis |
6.2.2 Jordan Human Microbiome-Based Drugs and Diagnostics Market Revenues & Volume, By Microbial Profiling, 2021 - 2031F |
6.2.3 Jordan Human Microbiome-Based Drugs and Diagnostics Market Revenues & Volume, By Microbial DNA Testing, 2021 - 2031F |
6.2.4 Jordan Human Microbiome-Based Drugs and Diagnostics Market Revenues & Volume, By Polymerase Chain Reaction (PCR), 2021 - 2031F |
6.2.5 Jordan Human Microbiome-Based Drugs and Diagnostics Market Revenues & Volume, By Genomic Profiling, 2021 - 2031F |
6.3 Jordan Human Microbiome-Based Drugs and Diagnostics Market, By Target Organism |
6.3.1 Overview and Analysis |
6.3.2 Jordan Human Microbiome-Based Drugs and Diagnostics Market Revenues & Volume, By Gut Microbiome, 2021 - 2031F |
6.3.3 Jordan Human Microbiome-Based Drugs and Diagnostics Market Revenues & Volume, By Oral Microbiome, 2021 - 2031F |
6.3.4 Jordan Human Microbiome-Based Drugs and Diagnostics Market Revenues & Volume, By Skin Microbiome, 2021 - 2031F |
6.3.5 Jordan Human Microbiome-Based Drugs and Diagnostics Market Revenues & Volume, By Vaginal Microbiome, 2021 - 2031F |
6.4 Jordan Human Microbiome-Based Drugs and Diagnostics Market, By Application Area |
6.4.1 Overview and Analysis |
6.4.2 Jordan Human Microbiome-Based Drugs and Diagnostics Market Revenues & Volume, By Gastrointestinal Health, 2021 - 2031F |
6.4.3 Jordan Human Microbiome-Based Drugs and Diagnostics Market Revenues & Volume, By Oral Health, 2021 - 2031F |
6.4.4 Jordan Human Microbiome-Based Drugs and Diagnostics Market Revenues & Volume, By Dermatological Disorders, 2021 - 2031F |
6.4.5 Jordan Human Microbiome-Based Drugs and Diagnostics Market Revenues & Volume, By Immune Modulation, 2021 - 2031F |
6.5 Jordan Human Microbiome-Based Drugs and Diagnostics Market, By End Use |
6.5.1 Overview and Analysis |
6.5.2 Jordan Human Microbiome-Based Drugs and Diagnostics Market Revenues & Volume, By Digestive Disorders, 2021 - 2031F |
6.5.3 Jordan Human Microbiome-Based Drugs and Diagnostics Market Revenues & Volume, By Periodontal Disease, 2021 - 2031F |
6.5.4 Jordan Human Microbiome-Based Drugs and Diagnostics Market Revenues & Volume, By Skin Health, 2021 - 2031F |
6.5.5 Jordan Human Microbiome-Based Drugs and Diagnostics Market Revenues & Volume, By Vaginal Health, 2021 - 2031F |
7 Jordan Human Microbiome-Based Drugs and Diagnostics Market Import-Export Trade Statistics |
7.1 Jordan Human Microbiome-Based Drugs and Diagnostics Market Export to Major Countries |
7.2 Jordan Human Microbiome-Based Drugs and Diagnostics Market Imports from Major Countries |
8 Jordan Human Microbiome-Based Drugs and Diagnostics Market Key Performance Indicators |
8.1 Number of clinical trials involving microbiome-based drugs and diagnostics in Jordan. |
8.2 Investment in research and development of microbiome-based therapies in the country. |
8.3 Adoption rate of microbiome-based diagnostics in healthcare institutions in Jordan. |
9 Jordan Human Microbiome-Based Drugs and Diagnostics Market - Opportunity Assessment |
9.1 Jordan Human Microbiome-Based Drugs and Diagnostics Market Opportunity Assessment, By Drug Category, 2021 & 2031F |
9.2 Jordan Human Microbiome-Based Drugs and Diagnostics Market Opportunity Assessment, By Diagnostic Category, 2021 & 2031F |
9.3 Jordan Human Microbiome-Based Drugs and Diagnostics Market Opportunity Assessment, By Target Organism, 2021 & 2031F |
9.4 Jordan Human Microbiome-Based Drugs and Diagnostics Market Opportunity Assessment, By Application Area, 2021 & 2031F |
9.5 Jordan Human Microbiome-Based Drugs and Diagnostics Market Opportunity Assessment, By End Use, 2021 & 2031F |
10 Jordan Human Microbiome-Based Drugs and Diagnostics Market - Competitive Landscape |
10.1 Jordan Human Microbiome-Based Drugs and Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 Jordan Human Microbiome-Based Drugs and Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here